Lanean...
Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
Tumor necrosis factor (TNF) is a central regulator of immunity. Due to its dominant pro-inflammatory effects, drugs that neutralize TNF were developed and are clinically used to treat inflammatory and autoimmune diseases, such as rheumatoid arthritis, inflammatory bowel disease and psoriasis. Howeve...
Gorde:
| Argitaratua izan da: | Front Cell Dev Biol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontiers Media S.A.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7264106/ https://ncbi.nlm.nih.gov/pubmed/32528961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.00401 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|